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Abstract
Rationale: There is evidence that impairments in nitric oxide (NO) signaling contribute to chronic hypoxia-induced
pulmonary hypertension. The L-arginine-NO precursor, L-citrulline, has been shown to ameliorate pulmonary hypertension.
Sodium-coupled neutral amino acid transporters (SNATs) are involved in the transport of L-citrulline into pulmonary arterial
endothelial cells (PAECs). The functional link between the SNATs, L-citrulline, and NO signaling has not yet been explored.
Objective: We tested the hypothesis that changes in SNAT1 expression and transport function regulate NO production by
modulating eNOS coupling in newborn piglet PAECs.
Methods and Results: A silencing RNA (siRNA) technique was used to assess the contribution of SNAT1 to NO production
and eNOS coupling (eNOS dimer-to-monomer ratios) in PAECs from newborn piglets cultured under normoxic and hypoxic
conditions in the presence and absence of L-citrulline. SNAT1 siRNA reduced basal NO production in normoxic PAECs and
prevented L-citrulline-induced elevations in NO production in both normoxic and hypoxic PAECs. SNAT1 siRNA reduced
basal eNOS dimer-to-monomer ratios in normoxic PAECs and prevented L-citrulline-induced increases in eNOS dimer-to-
monomer ratios in hypoxic PAECs.
Conclusions: SNAT1 mediated L-citrulline transport modulates eNOS coupling and thus regulates NO production in hypoxic
PAECs from newborn piglets. Strategies that increase SNAT1-mediated transport and supply of L-citrulline may serve as
novel therapeutic approaches to enhance NO production in patients with pulmonary vascular disease.
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Introduction
Infants with chronic cardiopulmonary disorders associated with
persistent or episodic hypoxia develop pulmonary hypertension.
Impairments in nitric oxide (NO) signaling may contribute to the
development of chronic hypoxia-induced pulmonary hypertension
[1,2]. NO production from endothelial nitric oxide synthase
(eNOS) is regulated in part by the availability of the substrate,
arginine, and the cofactor, tetrahydrobiopterin (BH4) [3,4,5]. In
the absence of sufficient arginine or BH4, eNOS activation
generates superoxide (O2
N2) instead of NO, a process known as
NOS uncoupling [3,4,5]. Mechanisms that drive NOS re-coupling
are poorly defined but provide potentially powerful therapeutic
targets. Since L-arginine promotes eNOS coupling, strategies that
effectively increase intracellular L-arginine availability to eNOS
could prove beneficial. While there is evidence that direct L-
arginine supplementation may be effective treatment in some
experimental models of pulmonary hypertension [5,6,7] detri-
mental effects of L-arginine supplementation have also been
reported and results from L-arginine treatment have been variable
[8,9,10,11]. Thus, alternate means for driving NOS re-coupling
and increasing NO production merit further exploration.
The L-arginine-NO precursor, L-citrulline, provides an alter-
nate approach to deliver bioavailable L-arginine for NO
production. There is evidence that in endothelial cells, L-citrulline
is converted by a two-step enzymatic process to L-arginine which
is directly channeled to eNOS for efficient NO production [9,12].
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Surprisingly, little is known about the transport of L-citrulline into
pulmonary arterial endothelial cells (PAECs). This knowledge
could provide another means to manipulate NO production.
We recently showed that sodium-coupled neutral amino acid
transporters (SNATs) are involved in transporting L-citrulline into
PAECs under both normoxic and hypoxic conditions [13].
Expression of SNAT1 is increased in PAECs cultured under
hypoxic conditions [13]. However, the link between SNAT1
expression, L-citrulline uptake, and NO signaling has not been
explored. The major purpose of this study was to test the
hypothesis that changes in SNAT1 expression and transport
function regulate NO production by modulating eNOS coupling
in newborn piglet PAECs.
Methods
Ethics statement
Use of animals conformed to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23) and was approved by the
Institutional Animal Care and Use Committee of Vanderbilt
University Medical Center, which is fully accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Use.
PAEC isolation
Using previously published methods [13], the main pulmonary
artery was isolated from the lungs of 5-day-old York-Landrace
mixed breed piglets, flushed with PBS, then filled with 0.25%
trypsin-EDTA and incubated for 5 min. To remove the endothe-
lial cells, the pulmonary artery was gently flushed with endothelial
growth medium (EGM-2, Lonza). Harvested endothelial cells were
cultured in EGM-2 in 100 mm plates in a humidified, normoxic
incubator (21% O2, 5% CO2) at 37uC. PAECs were identified by
their cobblestone morphology and eNOS-positive staining. Cells
were subcultured at near confluence and used at passages 4–10.
Modulation of SNAT1 expression
Using a modification of methods previously described [14],
PAECs were transfected with non-targeting (control) oligonucle-
otides (siGENOME Non-targeting siRNA #5) or SNAT1
targeting oligonucleotides (sense, 59-ACGAACAGCCAUUUG-
GAAAUU-39; anti-sense, 59-UUUCCAAAUGGCUGUUC-
GUUU-39; sense, 59-CCGGAAGAUGAUAACAUUAUU-39 an-
ti-sense, 59-UAAUGUUAUCAUCUUCCGGUU-39; anti-sense,
59-UAAUGUUAUCAUCUUCCGGUU-39; sense, 59-CA-
GUAACACUUCUGUCUAUUU-39 anti-sense, 59-AUAGACA-
GAAGUGUUACUGUU-39) purchased from Thermo Scientific.
For transfection, EGM-2 was replaced with OPTI-MEM (Gibco).
PAECs were transfected with a 300–600 pmol suspension of either
non-targeting or SNAT1 oligonucleotides (100–200 pmol for each
of the 3 different SNAT1 targeting oligonucleotides) using
lipofectamine (Invitrogen) in OPTI-MEM. After 4 hours, the
medium was replaced with EGM-2 and 10% FBS.
L-Citrulline uptake
After 48 hours in normoxic (21% O2, 5% CO2) or hypoxic (4%
O2, 5% CO2) conditions, PAECs were prepared for measuring L-
citrulline uptake using methods previously described [13]. PAEC
were washed with 2 mL fresh sodium-HEPES buffer composed of
the following: 2 mol/L NaCl, 2 mol/L KCl, 0.3 mol/L MgSO4,
0.325 mol/L CaCl2, 0.3 mol/L KH2PO4 and 1 mol/L HEPES
adjusted to pH of 7.4 with 1 mol/L NaOH. Cells were incubated
under normoxic conditions (21% O2, 5% CO2, 37uC) with
0.25 mCi/mL 14C-L-citrulline (specific activity: 56.3 mCi/mmol;
Perkin Elmer, Norwalk, CT, USA) in the presence of a saturating
concentration (200 mmol/L) of unlabeled L-citrulline. Incubations
were stopped after 5–10 min by washing three times with 2 mL
ice-cold sodium-HEPES buffer. All cells were lysed with 450 mL
1 mol/L NaOH for 30 min at 37uC. A 400 mL aliquot of each
lysate was transferred to a scintillation vial, LSC cocktail (Fisher
Scientific, Pittsburgh, PA, USA) was added and radioactivity was
measured in a scintillation counter (Beckman LS 6500; Brea, CA,
USA). The remainder of the lysate was used for protein
determination by bicinchoninic acid protein assay (Pierce, Rock-
ford, IL, USA). Uptake of L-citrulline was expressed as radioactive
counts per minute (CPM) per mg of protein.
NO measurement by ESR
PAECs were incubated under normoxic (21% O2, 5% CO2) or
hypoxic (4% O2, 5% CO2) conditions for 48 hours in basal media
(EGM-2), which contains 4 mmol/L L-citrulline. During the final
hour of the 48-hour incubation period, L-citrulline was added to
the medium of some cells to achieve a final conc. of 1 mmol/L.
Cells were washed with chilled Krebs-HEPES buffer and
incubated with calcium ionophore, A-23187 (10 mmol/L) and
200 mmol/L Fe(DETC)2 at 37uC for 1 hour. The cells were then
scraped in 0.5 ml of Krebs-HEPES buffer and snap-frozen in
liquid nitrogen and stored at 280uC until assessed for NO
production by electron spin resonance (ESR) as previously
described [14]. The amount of detected NO was determined
from the calibration curve for integral intensity of the ESR signal
of NO-Fe2+(MGD)2 prepared at various concentrations of the
NO-donor MAHMA-NONOate (ENZO Life Sciences Inc. NY,
USA).
Superoxide measurement using dihydroethidium and an
HPLC-based assay
Superoxide was measured using dihdroethidium (DHE) and an
HPLC-based assay as previously described [14]. PAECs were
cultured under normoxic or hypoxic conditions for 48 hours in
basal media (EGM-2), which contains 4 mmol/L L-citrulline.
During the final hour of the 48-hour incubation period, L-
citrulline was added to the medium of some cells to achieve a final
conc. of 1 mmol/L. PAECs were washed three times with chilled
Krebs-HEPES buffer and then incubated with 25 mmol/L
dihydroethidium for 20 min at 37uC in Krebs-HEPES buffer.
The cells were harvested in 0.3 ml of methanol, homogenized and
filtered through 0.22 mm filters and stored at 280uC until
analyzed by HPLC. Protein measurements by Bradford assay
were done in aliquots of homogenates collected prior to filtration.
Separation of ethidium, 2-hydroxyethidium, and dihydroethidium
was performed using a Beckman HPLC System Gold model with a
C-18 reverse phase column (Nucleosil 250, 4.5 mm; Sigma-
Aldrich, St. Louis, MO) equipped with both UV and fluorescence
detectors. Fluorescence detection at 580 nm (emission) and
480 nm (excitation) was used to monitor 2-hydroxyethidium
production. UV absorption at 355 nm was used for the detection
of dihydroethidium. The mobile phase was composed of a
gradient containing 60% acetonitrile and 0.1% trifluoroacetic
acid. Dihydroethidium, ethidium and 2-hydryoxyethidium were
separated by a linear increase in acetonitrile concentration from
37 to 47% over 23 min at a flow rate of 0.5 mL/min.
Hydroxyethidium was expressed per milligram protein.
SNAT1 and NO in Pulmonary Artery Endothelial Cells
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Immunoblot analysis of SNAT1, eNOS, and eNOS dimers
and monomers
PAECs were washed with PBS, then collected and stored at
280uC. Frozen PAECs were crushed under liquid N2 into a fine
powder, transferred to a tube containing homogenization buffer
with protease inhibitors, and then sonicated. Protein concentra-
tions for all homogenates were determined by the protein assay
(Bradford). For SNAT1 and eNOS analysis, using previously
described methods [13], supernatants were applied to tris-glycine
pre-cast 4–20% polyacrylamide gels (Invitrogen, Carlsbad, CA,
USA) so that equal amounts of protein were loaded. Electropho-
resis was carried out and the proteins were transferred from the gel
to a nitrocellulose membrane. The membrane was incubated at
room temperature in PBS containing 7.5% non-fat dried milk and
0.1% Tween-20 to block non-specific protein binding. To detect
SNAT1 or eNOS, the nitrocellulose membrane was incubated
overnight with the primary antibody (SNAT1 1:800, ABCAM;
eNOS 1:2000, eNOS antibody from BD-Transduction Laborato-
ry, San Diego, CA) diluted in PBS containing 0.1% Tween-20 and
1% non-fat dried milk (carrier buffer); followed by incubation with
a horseradish peroxidase-conjugated secondary antibody (Zymed)
diluted in the carrier buffer (1:5000). Using non-sonicated and
nonboiled lysates and low-temperature SDS-PAGE, eNOS
dimers/monomers were immunoblotted (1:2000, eNOS antibody,
BD-Transduction Laboratory, San Diego, CA) as described
elsewhere [15]. The membranes were developed using enhanced
chemiluminescence reagents (ECL, Amersham) and the chemilu-
minescent signal was captured on X-ray film (ECL Hyperfilm,
Kodak). Similar procedures were followed to reprobe the
membranes for b-actin (Sigma-Aldrich, St. Louis, MO) or
GAPDH (ABCAM, 1:1000). The bands for each protein were
quantified using densitometry.
Statistical Analysis
Data are presented as mean 6 SEM. Data were compared by
unpaired t-test or one-way ANOVA with Fisher’s protected least
significant difference (PLSD) post hoc comparison test as
appropriate. P-values ,0.05 were considered significant.
Figure 1. SNAT1 expression and L-citrulline uptake in PAECs cultured under normoxic or hypoxic conditions. Hypoxia increased both
the expression of the amino acid transporter, SNAT1 (A), and the uptake of 14C-L-citrulline (B) in PAECs (n = 11) from newborn piglets. In normoxic
PAECs (n = 11), SNAT1 siRNA reduced SNAT1 expression (A) without having a detectable impact on 14C-L-citrulline uptake (B: L-citrulline uptake in
normoxic PAECs treated with SNAT1 siRNA was 0.960.11; p = 0.4). *different from normoxia control siRNA, #different from hypoxia control siRNA;
P,0.05.
doi:10.1371/journal.pone.0085730.g001
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Results
Hypoxia increased SNAT1 expression (p,0.001; Fig. 1A) and
L-citrulline uptake (p= .003; Fig. 1B) in PAECs. In normoxic
PAECs, SNAT1 siRNA reduced SNAT1 expression (p = 0.04;
Fig. 1A) without having a detectable impact on L-citrulline uptake
(p = 0.4; Fig. 1 B). More importantly, SNAT1 siRNA inhibited the
hypoxia-induced elevation in SNAT1 expression (p,0.001;
Fig. 1A) and concomitantly prevented the hypoxia-induced
increase in L-citrulline uptake (p= 0.01; Fig. 1B). These findings
indicate that hypoxia increases L-citrulline uptake in PAECs via
SNAT1 and demonstrate an association between SNAT1 and the
transport of the L-arginine-NO substrate, L-citrulline, in PAECs of
newborn piglets.
To explore the role of L-citrulline and SNAT1 in modulating
NO signaling in PAECs, we determined the effects of L-citrulline
treatment and SNAT1 depletion by siRNA on NO production in
normoxic and hypoxic PAECs. L-citrulline significantly increased
NO production in both normoxic (p = 0.03; Fig. 2A) and hypoxic
(p = 0.005; Fig. 2B) PAECs. SNAT1 siRNA prevented the L-
citrulline-induced increase in NO production in both normoxic
(Fig. 2A; p = 0.4) and hypoxic PAECs (Fig. 2B, p = 0.21). These
findings show that L-citrulline-induced NO production is modu-
lated by SNAT1.
NO production is influenced by the state of eNOS coupling.
Uncoupled eNOS can be demonstrated as a loss of eNOS dimer
formation and an increase of eNOS monomers. We determined
the effects of L-citrulline treatment and SNAT1 siRNA on eNOS
dimer-to-monomer ratios in normoxic and hypoxic PAECs. L-
citrulline had no effect on the eNOS dimer-to-monomer ratio in
normoxic PAECs transfected with control siRNA (Fig. 3A and 3B;
p= 0.97). L-citrulline increased the eNOS dimer-to-monomer
ratio in normoxic PAECs transfected with SNAT1 siRNA (Fig. 3A
and 3B; p= 0.001). SNAT1 siRNA decreased both baseline eNOS
dimer-to-monomer ratios (Fig. 3A and 3B; p,0.001) and baseline
NO production (Fig. 2A; p = 0.03) in normoxic PAECs. Neither L-
citrulline nor SNAT1 siRNA altered total eNOS expression in
normoxic PAECs (Figure 4; p = 0.7). These data suggest that
SNAT1 knockdown reduced baseline NO production in normoxic
PAECs, at least in part, by uncoupling eNOS.
In hypoxic PAECs, L-citrulline increased eNOS dimer-to-
monomer ratios (Fig. 3A and 3C; p= 0.002), an effect that was
abolished by SNAT1 siRNA (Fig. 3A and 3C; p= 0.3). Total
eNOS expression was unchanged by L-citrulline and SNAT1
siRNA (Figure 4; p = 0.7). In conjunction with the NO data in
Figure 2 B, these findings suggest that L-citrulline and SNAT1
modulate NO production in hypoxic PAECs by influencing the
state of eNOS coupling.
We also determined the effects of L-citrulline treatment and
SNAT1 siRNA on O2
N2 production in normoxic and hypoxic
PAECs in the absence and presence of the NOS inhibitor, L-
NAME. L-citrulline had no effect on O2
N2 production in normoxic
PAECs transfected with control siRNA in either the presence or
absence of L-NAME, (Fig. 5A, p = 0.5 and 5C, p= 0.08). In
contrast, L-citrulline reduced O2
N2 production in normoxic
PAECs transfected with SNAT1 siRNA in the absence of L-
NAME (Fig. 5A, p = 0.036) but not the presence of L-NAME
(Fig. 5C, p= 0.9). Moreover, SNAT1 siRNA increased baseline
O2
N2 production in normoxic PAEC in the absence of L-NAME
(Fig. 5A; p = 0.008) but not the presence of L-NAME (Fig. 5C,
Figure 2. NO production in PAECs cultured under normoxic or hypoxic conditions. SNAT1 siRNA prevented L-citrulline-induced increases
in NO production in both normoxic (A, n = 5) and hypoxic (B, n = 5) PAECs from newborn piglets. A: for SNAT1 siRNA treated normoxic PAECs in the
absence vs presence of L-citrulline NO production was respectively, 6.460.5 and 7.861.0 AU/mg protein, p = 0.4. B: for SNAT1 siRNA treated hypoxic
PAECs in the absence vs presence of L-citrulline, NO production was respectively, 3.560.3 and 4.860.9 AU/mg protein, p = 0.21. *different from
baseline control siRNA, #different from citrulline-treated control siRNA, P,0.05.
doi:10.1371/journal.pone.0085730.g002
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p= 0.08). That is, in the presence of L-NAME (Fig. 5C), neither L-
citrulline nor SNAT1 siRNA caused changes in O2
N2 production
in normoxic PAECs. In addition, changes in O2
N2 production in
normoxic PAEC in the absence of L-NAME (Fig. 5A) were
concordant with changes in eNOS dimer-to-monomer ratios
(Fig. 3A and 3B). Taken together, these findings show that both L-
citrulline and SNAT1 modulate O2
N2 production in normoxic
PAECs in a NOS-dependent fashion that reflects the state of
eNOS coupling.
In the absence of L-NAME (Fig. 5 B), L-citrulline reduced O2
N2
production in hypoxic PAECs transfected with either control
siRNA (p= 0.01) or SNAT1 siRNA (p= 0.001). In the presence of
L-NAME, L-citrulline had no effect on O2
N2 production in
hypoxic PAECs transfected with control siRNA (Fig. 5D, p= 0.8).
However, in the presence of L-NAME, reductions in O2
N2
production with L-citrulline persisted in hypoxic PAECs trans-
fected with SNAT1 siRNA (p= 0.001; Fig. 5D). An increase in
baseline O2
N2 production occurred with SNAT1 siRNA in
hypoxic PAECs both in the absence (p =,0.001; Fig. 5B) and
presence (p =,0.001; Fig. 5D) of L-NAME. In the latter case, the
magnitude of increase in O2
N2 production was reduced by the
presence of L-NAME (increase in O2
N2 production was 4464% vs
2565% respectively in the absence vs the presence of L-NAME,
p,0.05). These findings show that both L-citrulline and SNAT1
modulate O2
N2 production in hypoxic PAECs in a NOS-
dependent fashion.
Discussion
Our studies reveal a number of novel findings regarding L-
citrulline and NO signaling in PAECs. We show for the first time
that the neutral amino acid transporter, SNAT1, modulates L-
citrulline-induced increases in NO production. Moreover, we
provide important new evidence that L-citrulline supplementation
increases NO production by re-coupling eNOS in a SNAT1-
dependent manner in hypoxic PAECs.
There are limited data on the transport of the amino acid, L-
citrulline, by neutral amino acid transporters in vascular cells [16].
Information about the impact of hypoxia on neutral amino acid
transporters, including SNAT1, in cells from vascular beds is also
scarce [17]. L-citrulline uptake was reported to remain unchanged
in PAECs from adult pigs cultured for up to 24 hours in hypoxia
[18]. However, we previously found that L-citrulline uptake was
increased in PAECs from newborn piglets cultured under hypoxic
conditions for 24, 48, or 72 hours [13]. Moreover, we provided
evidence that the hypoxia-induced increase in L-citrulline
transport involved the System A family of sodium-coupled neutral
amino acid transporters [13]. We confirm our previous findings
and extend them by identifying SNAT1 as the System A
transporter that is responsible for the enhanced ability to transport
L-citrulline in hypoxic PAECs.
To our knowledge, we are the first to provide evidence of an
important functional link between SNAT1, L-citrulline, and NO
Figure 3. eNOS dimers/monomers in PAECs cultured under normoxic or hypoxic conditions. Representative western blot (A);
densitometry for normoxic (B, n = 5) and hypoxic (C, n = 5) PAECs. In normoxic PAECs, L-citrulline had no effect on the eNOS dimer-to-monomer ratio
when transfected with control siRNA (A and B: in the absence vs presence of L-citrulline eNOS dimer-to-monomer ratio was respectively: 2.760.13
and 2.760.07, p = 0.97) but increased the eNOS dimer-to-monomer ratio when transfected with SNAT1 siRNA. In hypoxic PAECs, L-citrulline increased
eNOS dimer-to-monomer ratios when transfected with control siRNA but did not increase the eNOS dimer-to-monomer ratio when transfected with
SNAT1 siRNA (A and C: in the absence vs presence of L-citrulline, eNOS dimer-to-monomer ratio was respectively: 0.2860.003 vs 0.3760.07, p = 0.3).
*different from baseline control siRNA, #different from L-citrulline-treated control siRNA, +different from baseline SNAT1 siRNA; P,0.05.
doi:10.1371/journal.pone.0085730.g003
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signaling in PAECs. Others have shown that L-citrulline can
increase NO production in endothelial cells [19]. However, our
findings provide the first mechanistic evidence that SNAT1 is
integral to the effect of L-citrulline on NO production in both
normoxic and hypoxic PAECs. Furthermore, we are the first to
show that SNAT1 is involved in modulating eNOS uncoupling
and O2
N2 production in PAECs.
The role of SNAT1 in modulating eNOS re-coupling and O2
N2
production. differs between normoxic and hypoxic PAECs.
SNAT1 siRNA reduced baseline eNOS dimer formation and also
increased O2
N2 production in normoxic PAECs indicating that
SNAT1 is essential for either maintaining or promoting eNOS
dimerization under basal conditions, thereby impacting basal O2
N2
and NO production. However, despite transfection with SNAT1
siRNA, L-citrulline increased eNOS dimer-to-monomer ratios in
normoxic PAECs, suggesting that other transporters are involved
in the mechanism by which L-citrulline re-couples eNOS in
normoxic PAECs. In contrast, SNAT1 is integral to the ability of
L-citrulline to re-couple eNOS in hypoxic PAECs.
Findings in this study reveal additional novel information on the
mechanisms underlying L-citrulline-induced increases in NO
production. We have shown previously in an in vivo model that
L-citrulline supplementation increases pulmonary vascular NO
production and attenuates chronic hypoxia-induced pulmonary
hypertension in newborn piglets [20]. Findings herein provide
additional insight into the mechanisms by which L-citrulline might
alleviate pulmonary hypertension. We show that when hypoxic
PAECs are treated with L-citrulline there is a significant increase
in the eNOS dimer:monomer ratio, indicating that L-citrulline
reduces eNOS uncoupling. Consistent with eNOS re-coupling,
O2
N2 generation is reduced and NO production is increased in
hypoxic PAECs treated with L-citrulline. In addition, we
demonstrate that the decrease in O2
N2 seen with L-citrulline
supplementation is abolished by treatment with L-NAME, further
supporting that L-citrulline works in a NOS-dependent fashion.
Augmentation of NO production in normoxic PAECs occurs
without a change in the state of eNOS coupling. Under normoxic
conditions, eNOS dimers predominate making it biologically
unlikely and technically difficult to demonstrate that greater eNOS
coupling is driving enhanced NO production. The likely
explanation for the increase in NO production with L-citrulline
in normoxic PAECs is that, once transported into PAECs by
SNAT1, L-citrulline is enzymatically converted to L-arginine by
argininosuccinate synthetase (ASS) and argininosuccinate lyase
(ASL), increasing the intracellular pool of L-arginine that is
available to eNOS [9]. There is evidence that ASS-ASL-eNOS are
co-localized in plasmalemmal caveolae of endothelial cells [19].
Hence, instead of equilibrating with bulk intracellular levels, L-
citrulline induced increases in L-arginine could be directly
channeled to eNOS thereby driving NO production [12].
Our study has some limitations that merit discussion. All studies
were performed with PAECs isolated from the main pulmonary
artery of newborn piglets. Whether our findings reflect endothelial
cells from other species, other postnatal ages, all segments of the
Figure 4. Total eNOS measured under baseline conditions and with L-citrulline treatment in PAECs cultured under normoxic or
hypoxic conditions. A: representative western blot: B: densitometry for normoxic PAECs, n = 5; C: densitometry for hypoxic PAECs, n = 5. Neither L-
citrulline nor SNAT1 siRNA altered total eNOS expression in either normoxic or hypoxic PAECs.
doi:10.1371/journal.pone.0085730.g004
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pulmonary circulation, or other vascular beds will require future
exploration. We were unable to detect a significant reduction in L-
citrulline uptake in normoxic PAECs treated with SNAT1 siRNA.
Given the overlap of substrate specificity of amino acid transport-
ers, SNAT1 would not be expected to be the only L-citrulline
transporter. The presence of other transporters, which could
compensate for SNAT1 knockdown, likely led to an undetectable
net change in L-citrulline uptake in normoxic PAECs.
In summary, we provide novel, mechanistic data supporting an
integral role for SNAT1 in modulating L-citrulline-induced
changes in NO signaling in PAECs of newborn piglets. Our
findings have potential therapeutic significance and support a role
Figure 5. Superoxide production, as assessed by the formation of 2-hydroxyethidium, in PAECs cultured under normoxic or
hypoxic conditions. Normoxic PAECs (n = 5) in the absence (A) or presence (C) of L-NAME; Hypoxic PAECs (n = 5) in the absence (B) or presence (D)
of L-NAME. In normoxic conditions, L-citrulline had no effect on superoxide production in PAECs transfected with control siRNA in either the presence
(C) or absence (A) of L-NAME (A: O2
N2 production in the absence vs presence of L-citrulline was respectively, 625623 and 603628 pmol/mg protein,
p = 0.5 and C: O2
N2 production in the absence vs presence of L-citrulline was respectively, 670612 and 610628 pmol/mg protein, p = 0.08). L-
citrulline reduced superoxide production in PAECs transfected with SNAT1 siRNA in the absence (A) but not the presence (C) of L-NAME (C: O2
N2
production in the absence vs presence of L-citrulline was respectively, 613612 and 614613 pmol/mg protein, p = 0.9). Moreover, SNAT1 siRNA
increased baseline O2
N2 production in normoxic PAEC in the absence (A) but not the presence (C) of L-NAME (C: O2
N2 production for control siRNA vs
SNAT1 siRNA was respectively, 670612 and 613612 pmol/mg protein, p = 0.08). In hypoxic conditions, L-citrulline reduced superoxide production in
PAECs transfected with control siRNA in the absence (B) but not the presence of L-NAME (D: O2
N2 production in the absence vs presence of L-citrulline
was respectively, 711614 and 70369 pmol/mg protein, p = 0.8). L-citrulline reduced superoxide production in PAECs transfected with SNAT1 siRNA
in both the presence (D) and the absence (B) of L-NAME. *different from baseline control siRNA; #different from L-citrulline-treated control siRNA;
+different from baseline SNAT1 siRNA; P,0.05.
doi:10.1371/journal.pone.0085730.g005
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for L-citrulline supplementation as a means to reduce O2
N2
generation and increase NO production thereby ameliorating the
development of pulmonary hypertension in newborns. In addition,
our findings provide the impetus for future research to investigate
the possibility that manipulating L-citrulline transport could be a
viable therapeutic approach to modulate NO production in a
variety of vascular diseases.
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